Hartford Financial Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.62K Hold
10
﹤0.01% 289
2025
Q4
$6.77K Hold
10
﹤0.01% 281
2025
Q3
$6.39K Buy
10
+2
+25% +$1.21K ﹤0.01% 286
2025
Q2
$4.29K Hold
8
﹤0.01% 298
2025
Q1
$3.36K Hold
8
﹤0.01% 317
2024
Q4
$3.31K Hold
8
﹤0.01% 333
2024
Q3
$4.04K Hold
8
﹤0.01% 332
2024
Q2
$3.9K Hold
8
﹤0.01% 336
2024
Q1
$4.32K Hold
8
﹤0.01% 333
2023
Q4
$4.44K Buy
8
+2
+33% +$939 ﹤0.01% 337
2023
Q3
$2.62K Hold
6
﹤0.01% 358
2023
Q2
$3.01K Hold
6
﹤0.01% 329
2023
Q1
$3K Hold
6
﹤0.01% 329
2022
Q4
$2.45K Sell
6
-4
-40% -$1.55K ﹤0.01% 338
2022
Q3
$3K Hold
10
﹤0.01% 335
2022
Q2
$4K Hold
10
﹤0.01% 330
2022
Q1
$5K Buy
+10
New +$5.26K ﹤0.01% 332

Other funds holding IDXX

Hartford Financial Management's IDXX Position: Q1 2026 in Review

Hartford Financial Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 10 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Hartford Financial Management first reported a position in IDXX in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.77K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Hartford Financial Management held 10 shares of Idexx Laboratories worth $5.62K as of Q1 2026.
  • Hartford Financial Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Hartford Financial Management's portfolio in Q1 2026, its #289 holding.
  • Hartford Financial Management first reported a position in Idexx Laboratories in Q1 2022 and has held it in 17 quarters since.
  • Hartford Financial Management's Idexx Laboratories position peaked at $6.77K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.